Clinical Trial Update: Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma [Phase 4]

View source ↗

Summary

This clinical trial update reports a Phase 4 study of glofitamab as consolidation after first-line therapy in patients with high-risk diffuse large B-cell lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Columvi (glofitamab)

Snippet

Sponsor: Zhengzhou University | Conditions: B Cell Lymphoma (BCL) | Phase 4 | Status: NOT_YET_RECRUITING